What preoperative pulmonary evaluation is required before clearing a patient for atrial myxoma resection?

Preoperative Pulmonary Evaluation for Atrial Myxoma Surgery

For atrial myxoma resection, perform a focused preoperative pulmonary assessment that includes pulse oximetry, chest radiography if there are respiratory symptoms or risk factors for pulmonary complications, and baseline spirometry only if the patient has known pulmonary disease or symptoms—routine extensive pulmonary function testing is not required for uncomplicated cardiac surgery patients.

Risk Assessment Framework

The preoperative pulmonary workup for atrial myxoma surgery differs fundamentally from lung resection protocols. Unlike thoracic surgery where predicted postoperative lung function drives decision-making 1, 2, cardiac myxoma resection does not remove lung tissue, so the evaluation focuses on identifying patients at risk for postoperative pulmonary complications rather than calculating residual pulmonary reserve.

Key Risk Factors to Identify

Screen specifically for 3:

• Functional dependence (inability to perform activities of daily living)
• Advanced age (≥65 years)
• Chronic obstructive pulmonary disease (COPD)
• Congestive heart failure
• Recent weight loss
• Obstructive sleep apnea

These factors predict increased risk of perioperative pulmonary adverse events and warrant counseling about heightened risk.

Essential Preoperative Components

1. Cardiovascular Evaluation Takes Priority

Cardiac assessment supersedes pulmonary evaluation for myxoma surgery 1, 4. All patients require:

• Comprehensive echocardiography to assess myxoma size, location, mobility, and valve obstruction 5, 6
• ECG for all patients 7
• Evaluation for arrhythmias (common with atrial myxomas)
• Assessment of right or left heart failure secondary to valve obstruction

Critical caveat: Patients with obstructive myxomas (prolapsing into ventricles) have significantly higher risk of hemodynamic instability during induction—47.9% versus 24.2% in non-obstructive cases 5. This cardiac risk assessment is more predictive than pulmonary function.

2. Targeted Pulmonary Assessment

Perform these tests selectively, not routinely 4, 8:

• Pulse oximetry on room air: Universal baseline measurement
• Chest radiography: Only if respiratory symptoms present, known pulmonary disease, or risk factors for postoperative pulmonary complications 8
• Spirometry (FEV1) and DLCO: Reserve for patients with:
  • Known COPD or restrictive lung disease
  • Unexplained dyspnea beyond what cardiac pathology explains
  • Active pulmonary symptoms (chronic cough, wheezing)

Do NOT perform 8:

• Routine preoperative spirometry in asymptomatic patients
• Arterial blood gases unless oxygen saturation <90% on room air
• Exercise testing (this is for lung resection risk stratification, not cardiac surgery)

3. Special Considerations for Myxoma Patients

Unlike standard cardiac surgery, myxoma-specific concerns include 5, 6, 9:

• Embolic complications: 4.5% have cerebral thromboembolic events preoperatively 5—document any neurologic deficits
• Pulmonary embolism risk: Right atrial myxomas can embolize to pulmonary arteries 10, 11—if suspected, obtain CT pulmonary angiography
• Severe pulmonary hypertension: Can complicate weaning from bypass 12—echocardiographic estimation of pulmonary artery pressure is essential

What NOT to Do

Avoid these common pitfalls:

1. Do not apply lung resection guidelines 1, 7, 2—these require calculating predicted postoperative FEV1 and DLCO, which is irrelevant when no lung tissue is removed

2. Do not order routine preoperative testing batteries 4, 8—the 2002 ASA Practice Advisory and 2013 guidelines explicitly recommend against routine testing in the absence of clinical indications

3. Do not delay surgery for extensive pulmonary optimization unless active pulmonary disease requires treatment—myxomas carry risk of sudden death from obstruction or embolization 6, 9

Optimization Strategy

If pulmonary risk factors are identified 3:

• Active COPD: Optimize bronchodilator therapy, consider short course of corticosteroids if indicated
• Obstructive sleep apnea: Ensure CPAP compliance preoperatively; plan for postoperative continuation
• Respiratory infection: Treat and defer elective surgery until resolved
• Smoking: Counsel cessation, though evidence for benefit with short-term cessation before cardiac surgery is limited

Document clearly: Patients with multiple risk factors should have risks discussed in multidisciplinary conference 7, but this should not routinely delay urgent myxoma resection given embolic and obstructive risks.

Anesthetic Planning Implications

The pulmonary evaluation informs anesthetic management 5, 6, 9:

• Patients with obstructive myxomas may require femoral cannulation and cardiopulmonary bypass before induction to prevent cardiovascular collapse 9
• Severe pulmonary hypertension may necessitate pulmonary vasodilators for bypass weaning 12
• Known pulmonary disease guides ventilation strategies and extubation timing

The preoperative pulmonary assessment is a risk stratification tool, not a clearance hurdle—surgery proceeds unless prohibitive active pulmonary pathology exists requiring treatment.